Biotechnology/Chemical/Pharmaceutical Customer Partnership

Wednesday, March 12, 2008

United States Patent and Trademark Office
Alexandria, Virginia
Madison Auditorium South 600 Dulany Street, Alexandria, VA

The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on December 4, 2007 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.

We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.

The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Wednesday, March 12, 2008 from 9:00 am to 4:30 pm at Auditorium South in Madison East, 600 Dulany Street, Alexandria, Virginia.

For information of future meetings and presentations, please go to http://www.cabic.com/bcp/. Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by March 6, 2008.

---

The meeting is also available online. Here is the link ( On-Line Meeting ).

Time	Morning Session	Presenter
9:00-9:15	Greetings and Overview	John LeGuyader, Bruce Kisliuk, Christopher Low, Directors, Technology Center 1600
9:15-10:00	Patent Prosecution Highway	Pinchus Laufer, Office of Patent Legal Administration
10:00-10:45	Biotechnology, Chemistry and Pharmaceuticals in the Mechanical Arts	Thomas Barrett, SPE, TC3700
10:45-11:00	Break
11:00-12:00	Restriction Petition Update and Rejoinder Practice	Julie Burke, QAS/PM, TC1600
12:00-1:15	Lunch

Time	Afternoon Session	Presenter
1:15-2:00	Enablement in Claims to Various Forms of Compounds	James Wilson, SPE, Art Unit 1624
2:00-2:45	Bioinformatics and 35 USC 101	Marjorie Moran, SPE, Art Unit 1631
2:45-3:00	Break
3:00-4:00	Enablement in Claims to Therapeutic Treatment	Jean Witz, QAS, TC1600
4:00-4:15	Closing Remarks/Discussion	John LeGuyader, Bruce Kisliuk, Christopher Low, Directors, Technology Center 1600